159992 创新药
已收盘 05-15 15:00:00
资讯
新帖
简况
全球首创新药“硬实力”领跑，丹诺医药-B(06872)开启招股掘金抗感染赛道
智通财经 · 05-15 16:30
全球首创新药“硬实力”领跑，丹诺医药-B(06872)开启招股掘金抗感染赛道
《药品试验数据保护实施办法》发布 国家药监局：予创新药试验数据6年保护期
智通财经 · 05-15 15:20
《药品试验数据保护实施办法》发布 国家药监局：予创新药试验数据6年保护期
创新药概念局部异动
第一财经 · 05-15 09:50
创新药概念局部异动
港股通创新药三连跌，520880持续溢价交易，此前10日吸金超4.34亿元！出海与政策双线驱动，机构提示配置机遇
新浪基金 · 05-14 10:45
港股通创新药三连跌，520880持续溢价交易，此前10日吸金超4.34亿元！出海与政策双线驱动，机构提示配置机遇
中国生物制药附属减肥创新药亮相欧洲大会：体外活性提升10倍以上，联合用药脂肪减少量提高1.5-2倍
财中社 · 05-14 08:53
中国生物制药附属减肥创新药亮相欧洲大会：体外活性提升10倍以上，联合用药脂肪减少量提高1.5-2倍
润都股份：公司近期获批的盐酸去甲乌药碱注射液为全球首创新药
证券之星 · 05-14 08:51
润都股份：公司近期获批的盐酸去甲乌药碱注射液为全球首创新药
众生药业：ZSP1601片是治疗MASH首创一类创新药
证券之星 · 05-14 08:48
众生药业：ZSP1601片是治疗MASH首创一类创新药
创新药板块震荡下挫，港股通创新药ETF易方达（159316）逆势获5000万份净申购
证券之星 · 05-13 19:50
创新药板块震荡下挫，港股通创新药ETF易方达（159316）逆势获5000万份净申购
今日昂利康（002940）涨停分析：集采中选、创新药与宠物药驱动
证券之星 · 05-13 15:46
今日昂利康（002940）涨停分析：集采中选、创新药与宠物药驱动
创新药再爆百亿BD大单！华宝基金药ETF逆市连阳！多头提前埋伏，连续4日爆买520880！
新浪基金 · 05-12
创新药再爆百亿BD大单！华宝基金药ETF逆市连阳！多头提前埋伏，连续4日爆买520880！
国泰海通：1Q26行业趋势延续向好 创新药仍是医药板块景气主线
智通财经 · 05-12
国泰海通：1Q26行业趋势延续向好 创新药仍是医药板块景气主线
小摩：医保目录调整加速创新药商业化 首选信达生物(01801)等
智通财经网 · 05-12
小摩：医保目录调整加速创新药商业化 首选信达生物(01801)等
利好突袭！3800亿巨头直线拉升，百亿美元大单引爆创新药概念
21世纪经济报道 · 05-12
利好突袭！3800亿巨头直线拉升，百亿美元大单引爆创新药概念
创新药概念局部异动
第一财经 · 05-12
创新药概念局部异动
恒瑞医药与BMS达成全球重磅合作，携手开发13款早期创新药
老虎资讯综合 · 05-12
恒瑞医药与BMS达成全球重磅合作，携手开发13款早期创新药
一品红：公司在研的创新药氘泊替诺雷（AR882）是一种高效选择性尿酸转运蛋白（URAT1）抑制剂，用于降低血尿酸治疗痛风及溶解痛风石
证券之星 · 05-12
一品红：公司在研的创新药氘泊替诺雷（AR882）是一种高效选择性尿酸转运蛋白（URAT1）抑制剂，用于降低血尿酸治疗痛风及溶解痛风石
今日南新制药（688189）涨停分析：创新药进展、财务优化与控股股东支持驱动
证券之星 · 05-11
今日南新制药（688189）涨停分析：创新药进展、财务优化与控股股东支持驱动
港股异动 | 迈威生物-B(02493)午后涨近5% 创新药9MW5211临床试验申请获FDA许可
智通财经网 · 05-11
港股异动 | 迈威生物-B(02493)午后涨近5% 创新药9MW5211临床试验申请获FDA许可
港股通创新药大举吸金，520880单周获超3.5亿元净申购！管线布局逐步兑现，机构：创新药值得重点关注
新浪基金 · 05-11
港股通创新药大举吸金，520880单周获超3.5亿元净申购！管线布局逐步兑现，机构：创新药值得重点关注
泰恩康最新公告：拟发行不超8.7亿元可转债用于创新药等项目
证券之星 · 05-08
泰恩康最新公告：拟发行不超8.7亿元可转债用于创新药等项目
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"159992","market":"SZ","secType":"STK","nameCN":"创新药","latestPrice":0.798,"timestamp":1778828601000,"preClose":0.803,"halted":0,"volume":985353240,"delay":0,"changeRate":-0.0062,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.005,"latestTime":"05-15 15:00:00","open":0.802,"high":0.814,"low":0.794,"amount":791000000,"amplitude":0.0249,"askPrice":0.799,"askSize":14887,"bidPrice":0.798,"bidSize":29024,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":0.803,"symbolType":"fund","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":0.883,"lowLimit":0.723,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":-0.044527,"marketValue":0,"turnoverRate":0,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-05-18。","floatMarketCap":0},"requestUrl":"/m/hq/s/159992/","defaultTab":"news","newsList":[{"id":"2635704654","title":"全球首创新药“硬实力”领跑，丹诺医药-B(06872)开启招股掘金抗感染赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2635704654","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635704654?lang=zh_cn&edition=full","pubTime":"2026-05-15 16:30","pubTimestamp":1778833820,"startTime":"0","endTime":"0","summary":"5月6日，丹诺医药(苏州)股份有限公司顺利通过港交所主板上市聆讯，并已于5月14日正式开启招股，中信证券、农银国际担任联席保荐人。弗若斯特沙利文数据显示，幽门螺杆菌感染作为全球范围内的高发疾病，2024年全球治疗市场规模69亿美元，预计至2035年将攀升至161亿美元。在幽门螺杆菌感染治疗领域之外，丹诺医药在植入体相关细菌生物膜感染治疗方面同样取得了重要突破。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","159992","06978","BK1161","BK1574","06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635706477","title":"《药品试验数据保护实施办法》发布 国家药监局：予创新药试验数据6年保护期","url":"https://stock-news.laohu8.com/highlight/detail?id=2635706477","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635706477?lang=zh_cn&edition=full","pubTime":"2026-05-15 15:20","pubTimestamp":1778829648,"startTime":"0","endTime":"0","summary":"第十一条对符合数据保护条件的药品，国家药监局在药品批准证明文件中标注该药品的数据保护信息。数据保护终止的，国家药监局发布终止数据保护公告，药审中心根据公告，更新数据保护专栏中的相关信息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","159992","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635737027","title":"创新药概念局部异动","url":"https://stock-news.laohu8.com/highlight/detail?id=2635737027","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635737027?lang=zh_cn&edition=full","pubTime":"2026-05-15 09:50","pubTimestamp":1778809834,"startTime":"0","endTime":"0","summary":"创新药概念局部异动","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605153738502053.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605153738502053.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1161","06978","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635336766","title":"港股通创新药三连跌，520880持续溢价交易，此前10日吸金超4.34亿元！出海与政策双线驱动，机构提示配置机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2635336766","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635336766?lang=zh_cn&edition=full","pubTime":"2026-05-14 10:45","pubTimestamp":1778726700,"startTime":"0","endTime":"0","summary":"5月14日早盘，港股通创新药冲高回落，权重龙头集体飘绿，康方生物、三生制药跌逾3%，百济神州、石药集团、翰森制药跌逾1%。100%创新药研发标的——港股通创新药ETF华宝现跌1.46%，振幅超2.7%，连续3日下跌。 值得关注的是，520880场内延续宽幅溢价，显示买盘资金仍活跃。近期板块震荡下行区间，资金频频增仓，截至5月13日，520880近10日累计吸金超4.3亿元。 产业方面，日前恒瑞医药与BMS达成152亿美元全球合作，首付款6亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-05-14/doc-inhxvpqn0184733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","520880","06978","BK1161","VXUS","BK4588","BK4585","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635768379","title":"中国生物制药附属减肥创新药亮相欧洲大会：体外活性提升10倍以上，联合用药脂肪减少量提高1.5-2倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2635768379","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635768379?lang=zh_cn&edition=full","pubTime":"2026-05-14 08:53","pubTimestamp":1778719980,"startTime":"0","endTime":"0","summary":"5月14日，中国生物制药（01177）发布公告，本公司附属公司正大天晴药业集团股份有限公司自主开发的创新药TQF6422“ActRIIA/B单抗”临床前研究数据已于2026年欧洲肥胖大会（ECO）公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605143736704546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1589","BK1191","BK1515","BK1574","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","06978","IE00BZ08YS42.EUR","BK1521","HK0000165453.HKD","01177","BK1161","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635750130","title":"润都股份：公司近期获批的盐酸去甲乌药碱注射液为全球首创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2635750130","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635750130?lang=zh_cn&edition=full","pubTime":"2026-05-14 08:51","pubTimestamp":1778719868,"startTime":"0","endTime":"0","summary":"证券之星消息，润都股份05月13日在投资者关系平台上答复投资者关心的问题。关于您提出的问题，现回复如下： 1、公司近期获批的盐酸去甲乌药碱注射液为全球首创新药。随着公司对该创新药优势的学术推广和国家对精准诊疗理念的普及，盐酸去甲乌药碱注射液有望惠及更多患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400008437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","BK1574","BK1161","002923","06978","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635750938","title":"众生药业：ZSP1601片是治疗MASH首创一类创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2635750938","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635750938?lang=zh_cn&edition=full","pubTime":"2026-05-14 08:48","pubTimestamp":1778719692,"startTime":"0","endTime":"0","summary":"证券之星消息，众生药业05月13日在投资者关系平台上答复投资者关心的问题。请问公司1601非酒精型脂肪肝创新药对酒精性脂肪肝是否具有治疗效果？公司ZSP1601片是具有全球自主知识产权、全新作用机制的治疗代谢功能障碍相关脂肪性肝炎首创一类创新药，为国家重大新药创制项目。公司始终以满足未被满足的临床需求为导向，未来，公司将根据实际情况，综合考虑ZSP1601片的适应症拓展，相关信息请以公司公告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400008417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK1161","002317","159992","BK0188","BK0239","BK1574","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635278144","title":"创新药板块震荡下挫，港股通创新药ETF易方达（159316）逆势获5000万份净申购","url":"https://stock-news.laohu8.com/highlight/detail?id=2635278144","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635278144?lang=zh_cn&edition=full","pubTime":"2026-05-13 19:50","pubTimestamp":1778673024,"startTime":"0","endTime":"0","summary":"5月13日，创新药赛道震荡下挫，截至收盘，恒生港股通创新药指数下跌1.9%，中证创新药产业指数下跌1.3%，资金逆势布局，港股通创新药ETF易方达全天净申购达5000万份。兴业证券表示，中国创新药具备高效率、低成本的开发优势，在热门技术赛道如 ADC、双抗、小核酸等具备竞争优势，有望持续展现行业竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026051300039856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1574","159992","06978","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635850209","title":"今日昂利康（002940）涨停分析：集采中选、创新药与宠物药驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2635850209","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635850209?lang=zh_cn&edition=full","pubTime":"2026-05-13 15:46","pubTimestamp":1778658379,"startTime":"0","endTime":"0","summary":"证券之星消息，昂利康5月13日涨停收盘，收盘价36.43元。今日昂利康涨停的可能因素有：1、12个产品拟中选国家集采接续采购，对应2024年营收占比13.93%，中标可获2–3年稳定销售周期；2、创新药ALK-N001研发持续推进并进入临床阶段，11.2亿元定增资金全部投入创新药研发；3、宠物药布局加速落地，获批‘吸入用七氟烷（宠物用）’等批件，覆盖超4000家宠物医院；4、2025年业绩预增显著，归母净利润预计增长36.93%–71.78%，扣非净利润增长46.68%–104.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300023985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","159992","002940","BK1161","06978","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215477","title":"创新药再爆百亿BD大单！华宝基金药ETF逆市连阳！多头提前埋伏，连续4日爆买520880！","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215477","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634215477?lang=zh_cn&edition=full","pubTime":"2026-05-12 19:38","pubTimestamp":1778585880,"startTime":"0","endTime":"0","summary":"5月12日，AH创新药整体延续调整。午间恒瑞医药官宣重磅BD，其A股暴拉涨停，H股一度冲涨16%，带动板块直线拉升翻红。 A股制药板块午后自深水区拉起，场内唯一药ETF华宝*直线冲高1.73%根据PCF清单，恒瑞医药为药ETF华宝第一大权重股，最新权重占比14.13%。 截至收盘，药ETF华宝逆市收涨，成功连阳站上10日线。2026年一季度，中国创新药对外BD的平均首付款为1.8亿美元，相比2025年增长59%，相比5年前更是大涨187%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-05-12/doc-inhxrwqe1459758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1574","06978","159992","520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634295796","title":"国泰海通：1Q26行业趋势延续向好 创新药仍是医药板块景气主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2634295796","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634295796?lang=zh_cn&edition=full","pubTime":"2026-05-12 15:57","pubTimestamp":1778572645,"startTime":"0","endTime":"0","summary":"创新药销售与BD收入形成双轮驱动，行业增长结构持续优化2025年药企创新药相关收入，即创新药销售收入与BD收入合计约1940亿元，同比+35%，占药品板块总收入比例已提升至42%。商业化Biotech受益于收入规模快速扩大，销售费用率明显摊薄，盈利拐点进一步明确。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK1574","159992","BK0276","02611","BK1147","BK0183","159938","601211","09939","BK1564","BK0188","BK0028","BK0201","BK1515","BK0184","BK1161","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634296521","title":"小摩：医保目录调整加速创新药商业化 首选信达生物(01801)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2634296521","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634296521?lang=zh_cn&edition=full","pubTime":"2026-05-12 14:23","pubTimestamp":1778567022,"startTime":"0","endTime":"0","summary":"摩根大通重申对信达生物(01801)、科伦博泰生物-B(06990)、药明康德(02359) 及药明合联(02268)的正面看法，并将其列为行业首选股。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260512/20260512142400_17997.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260512/20260512142400_17997.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440606.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["JPO","LU0345769631.USD","IE00B1BXHZ80.USD","LU2417539215.USD","LU0345770993.USD","LU0455707207.USD","SG9999002232.USD","LU0070302665.USD","LU1551013425.SGD","LU0320765646.SGD","LU0868494617.USD","LU1244550221.USD","LU0502904849.HKD","LU1974910355.USD","LU2054465674.USD","IE0034235303.USD","LU0170899867.USD","LU0976567544.SGD","159992","IE00BJTD4N35.SGD","BK4516","BK4533","IE00B1XK9C88.USD","LU0820562030.AUD","06978","01801","LU0211326755.USD","LU0234572021.USD","LU0238689110.USD","LU0211331839.USD","LU2756315664.SGD","BK4504","IE00BLSP4239.USD","LU0820561818.USD","JPMO","LU0683600562.USD","LU0320765489.SGD","BK4550","LU2505996509.AUD","BK4534","LU2264538146.SGD","LU1548497426.USD","LU2456880835.USD","IE00B775SV38.USD","BK4588","LU2552382215.SGD","LU2357627491.SGD","LU1894683264.USD","IE00BFXG1179.USD","LU1064131342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634625572","title":"利好突袭！3800亿巨头直线拉升，百亿美元大单引爆创新药概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2634625572","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634625572?lang=zh_cn&edition=full","pubTime":"2026-05-12 14:14","pubTimestamp":1778566440,"startTime":"0","endTime":"0","summary":"5月12日，创新药概念局部异动。其中，恒瑞医药（600276.SH）午后直线拉涨，随后回落，截至13:35，报56.61元/股，涨5.77%，总市值3757亿元；重药控股（000950.SZ）、津药药业（600488.SH）涨停，华兰股份（301093.SZ）、成都先导（688222.SH）等多只概念股涨超5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605123734373335.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605123734373335.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159992","06978","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634269896","title":"创新药概念局部异动","url":"https://stock-news.laohu8.com/highlight/detail?id=2634269896","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634269896?lang=zh_cn&edition=full","pubTime":"2026-05-12 13:07","pubTimestamp":1778562453,"startTime":"0","endTime":"0","summary":"创新药概念局部异动","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605123734314845.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605123734314845.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1161","159992","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198821818","title":"恒瑞医药与BMS达成全球重磅合作，携手开发13款早期创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=1198821818","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198821818?lang=zh_cn&edition=full","pubTime":"2026-05-12 13:03","pubTimestamp":1778562223,"startTime":"0","endTime":"0","summary":"5月12日，$恒瑞医药(01276)$午后直线拉升，一度涨超16%！该公司与BMS达成全球重磅合作，携手开发13款早期创新药。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b1f4c1fa965d76d4e78087079f689b4e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"恒瑞医药与BMS达成全球重磅合作，携手开发13款早期创新药","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997245094.SGD","600276","BK0060","LU2580892862.HKD","LU2097828805.USD","LU2097828714.EUR","BK1161","LU1997244956.HKD","LU1255011170.USD","LU2328871848.SGD","LU2148510915.USD","LU0359202008.SGD","LU2488822045.USD","LU2543165471.USD","01276","LU2289578879.USD","LU1023057109.AUD","BK0196","LU1146622755.USD","LU2097828474.EUR","LU1580142542.USD","BK1574","159992","LU1655091616.SGD","LU0405327494.USD","LU0405327148.USD","LU2097828557.USD","LU0359201612.USD","BMY","BK0188","BK0028","LU1781817850.SGD","LU1064130708.USD","BK1191","LU2580892789.USD","BK0239","BK0012","LU2495084118.USD","LU1328615791.USD","BK0183","LU1997245177.USD","LU1064131003.USD","LU1820825898.SGD","LU1969619763.USD","LU2097828631.EUR","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2634268476","title":"一品红：公司在研的创新药氘泊替诺雷（AR882）是一种高效选择性尿酸转运蛋白（URAT1）抑制剂，用于降低血尿酸治疗痛风及溶解痛风石","url":"https://stock-news.laohu8.com/highlight/detail?id=2634268476","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634268476?lang=zh_cn&edition=full","pubTime":"2026-05-12 11:33","pubTimestamp":1778556808,"startTime":"0","endTime":"0","summary":"证券之星消息，一品红(300723)05月11日在投资者关系平台上答复投资者关心的问题。投资者提问：5月15日,ASCO会摘录贵公司疼风药第三期临床结果吗一品红回复：尊敬的投资者您好，感谢您对公司的关注。ASCO是临床肿瘤学领域的学术会议。公司在研的创新药氘泊替诺雷（AR882）是一种高效选择性尿酸转运蛋白（URAT1）抑制剂，用于降低血尿酸治疗痛风及溶解痛风石。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200016638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","06978","BK1161","BK1574","BK0239","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634405166","title":"今日南新制药（688189）涨停分析：创新药进展、财务优化与控股股东支持驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2634405166","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634405166?lang=zh_cn&edition=full","pubTime":"2026-05-11 15:40","pubTimestamp":1778485203,"startTime":"0","endTime":"0","summary":"证券之星消息，南新制药5月11日涨停收盘，收盘价10.55元。该股于13点9分涨停，未打开涨停，截止收盘封单资金为4415.7万元，占其流通市值1.53%。5月11日的资金流向数据方面，主力资金净流入6460.46万元，占总成交额19.05%，游资资金净流出3079.1万元，占总成交额9.08%，散户资金净流出3381.37万元，占总成交额9.97%。近5日资金流向一览见下表：该股为流感，创新药，医药概念热股，当日流感概念上涨1.95%，创新药概念上涨1.85%，医药概念上涨1.58%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100015781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","BK1161","06978","688189","BK1574","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634472914","title":"港股异动 | 迈威生物-B(02493)午后涨近5% 创新药9MW5211临床试验申请获FDA许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2634472914","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634472914?lang=zh_cn&edition=full","pubTime":"2026-05-11 13:57","pubTimestamp":1778479078,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，迈威生物-B午后涨近5%，截至发稿，涨3.54%，报27.52港元，成交额3326.31万港元。消息面上，迈威生物宣布，其自主研发的抗体创新药9MW5211的临床试验申请正式获得美国食品药品监督管理局的许可，可针对炎症性肠病开展临床研究。其用于IBD和多发性硬化等多个适应症的临床试验申请已获国家药品监督管理局受理。9MW5211在其靶点上是全球首款进入临床阶段的候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440081.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","BK4588","BK1161","BK4585","159992","06978","02493","BK0239","LABU","688062","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634473344","title":"港股通创新药大举吸金，520880单周获超3.5亿元净申购！管线布局逐步兑现，机构：创新药值得重点关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2634473344","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634473344?lang=zh_cn&edition=full","pubTime":"2026-05-11 10:06","pubTimestamp":1778465160,"startTime":"0","endTime":"0","summary":"周一早盘，港股通创新药继续调整，100%创新药研发标的——港股通创新药ETF华宝跌逾1%。权重股普跌，康方生物、信达生物、百济神州、石药集团齐跌逾2%，三生制药跌超3%。 值得关注的是，港股通创新药ETF华宝场内再现高溢价，显示买盘活跃。上周，520880周线收出三连阴，当周累获逾3.57亿元逆市净申购！回归基本面来看，H股创新药管线布局逐步兑现，盈利能力改善。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-05-11/doc-inhxnscs2483673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","BK1161","BK4588","BK1574","159992","520880","BK4585","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633471459","title":"泰恩康最新公告：拟发行不超8.7亿元可转债用于创新药等项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2633471459","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633471459?lang=zh_cn&edition=full","pubTime":"2026-05-08 20:50","pubTimestamp":1778244659,"startTime":"0","endTime":"0","summary":"泰恩康(301263.SZ)公告称，公司拟向不特定对象发行可转换公司债券，募集资金总额不超过8.7亿元(含本数)，扣除发行费用后拟用于创新药研发项目、创新药及高端外用制剂产业化建设项目、华铂凯盛制剂生产基地项目及亳州泰恩康现代中药制剂产线建设项目(一期)。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800041117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","159992","301263","BK1574","06978","BK0250"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778901709475,"stockEarnings":[{"period":"1week","weight":-0.0327},{"period":"1month","weight":-0.0838},{"period":"3month","weight":-0.0409},{"period":"6month","weight":-0.124},{"period":"1year","weight":0.0887},{"period":"ytd","weight":-0.0397}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创新药(159992)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创新药(159992)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创新药,159992,创新药股票,创新药股票老虎,创新药股票老虎国际,创新药行情,创新药股票行情,创新药股价,创新药股市,创新药股票价格,创新药股票交易,创新药股票购买,创新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创新药(159992)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创新药(159992)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}